Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction


Very frequent loss of heterozygosity (LOH) on chromosome 3p has been found in human renal cell carcinoma (RCC). In the present study, we examined LOH at the retinoblastoma (RB), mutated in colorectal cancer (MCC) and adenomatous polyposis coli (APC) tumour suppressor genes loci, and mutations of the H-, K-, and N-ras oncogenes. We performed these studies using the polymerase chain reaction (PCR) method followed by restriction fragment length polymorphism (RFLP) and single-strand conformation polymorphism (SSCP) analyses. LOH was detected in 2 of 11 (18.2%), and 2 of 14 (14.3%) informative cases at the MCC and APC loci, respectively, and in none of 15 informative cases at the RB locus in 25 RCCs. LOH at the MCC was accompanied by LOH at the APC locus in two RCCs. No mutation was detected in H-, K-, and N-ras genes in 39 RCCs. Thus, alterations of the known tumour suppressor genes and the ras oncogenes were infrequent events in RCC. The results suggest that the genetic pathway in the genesis of RCC differs considerably from that of other common human carcinomas.

This is a preview of subscription content, log in to check access.


  1. 1.

    Alfred G, Knudson JR (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823

  2. 2.

    Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine panceras contain mutant c-K-ras genes. Cell 53: 549–554

  3. 3.

    Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P, Sheer D, Solomon E, Spurr NK (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614–616

  4. 4.

    Bos JL, Fearon ER, Hamilton SR, Vries MV-d, van Boom JH, van der Eb AJ, Vogelstein B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293–297

  5. 5.

    Boynton RF, Blount PL, Yin J, Brown VL, Huang Y, Tong Y, McDaniel T, Newkirk C, Resau JH, Raskind WH, Haggitt RC, Reid BJ, Meltzer SJ (1992) Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA 89: 3385–3388

  6. 6.

    D'Amico D, Carbone DP, Johnson BE, Meltzer SJ, Minna JD (1992) Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res 52: 1996–1999

  7. 7.

    Ding S-F, Habib NA, Dooley HJ, Wood C, Bowles L, Delhanty JDA (1991) Loss of contitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 64: 1083–1087

  8. 8.

    Friend SH, Horowitz JM, Gerber MR, Wang X-F, Bogenmann E, Li FP, Weinberg RA (1987) Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 84: 9059–9063

  9. 9.

    Fujita J, Kraus MH, Onoue H, Srivastava SK, Ebi Y, Kitamura Y, Rhim JS (1988) Activated H-ras oncogenes in human kidney tumors. Cancer Res 48: 5251–5255

  10. 10.

    Groffen J, Heisterkamp N, Spurr NK, Dana SL, Wasmuth JJ, Stephenson JR (1984) Regional assignment of the human c-fms oncogene to band q34 of chromosome 5 (HGM7). Cytogenet Cell Genet 37: 484–488

  11. 11.

    Hermanek P, Sobin LH (eds) (1987) TNM Classification of malignant tumors (4th edn) Springer, Berlin Heidelberg New York

  12. 12.

    Holstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutation in human cancers. Science 253: 49–53

  13. 13.

    Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y, Nakamura Y (1992) Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 52: 6696–6698

  14. 14.

    Ishikawa J, Xu H-J, Hu S-X, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R (1991) Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 51: 5736–5743

  15. 15.

    Kinzler KW, Nilbert MC, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hamilton SR, Hegde P, Markham A, Carlson M, Joslyn G, Groden J, White R, Miki Y, Miyoshi Y, Nishisho I, Nakamura Y (1991) Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251: 1366–1370

  16. 16.

    Kovacs G, Szücs S, De Riese W, Baumgärtel H (1987) Specific chromosome aberration in human renal cell carcinoma. Int J Cancer 40: 171–178

  17. 17.

    Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G, Sümegi J (1988) Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85: 1571–1575

  18. 18.

    Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan D-SR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Paslier DL, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317–1320

  19. 19.

    Lee EY-HP, To H, Shew JY, Bookstein R, Scully P, Lee WH (1988) Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241: 218–221

  20. 20.

    Leppert M, Dobbs M, Scambler P, O'Connell P, Nakamura Y, Stauffer D, Woodward S, Burt R, Huges J, Gardner E, Lathrop M, Wasmuth J, Lalouel J-M, White R (1987) The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238: 1411–1413

  21. 21.

    Miki Y, Nishisho I, Miyoshi Y, Horii A, Ando H, Nakajima T, Utsunomiya J, Nakamura Y (1991) Frequent loss of heterozygosity at MCC locus on chromosome 5q21–22 in sporadic colorectal carcinomas. Jpn J Cancer Res 82: 1003–1007

  22. 22.

    Mizuuchi H, Nasim S, Kudo R, Silverberg SG, Greenhouse S, Garrett CT (1992) Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium. Cancer Res 52: 2777–2781

  23. 23.

    Morita R, Ishikawa J, Tsutsumi M, Hikiji K, Tsukada Y, Kamidono S, Maeda S, Nakamura Y (1991a) Allelotype of renal cell carcinoma. Cancer Res 51: 820–823

  24. 24.

    Morita R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K, Nakamura Y (1991b) Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res 51: 5817–5820

  25. 25.

    Murakami Y, Hayashi K, Hirohashi S, Sekiya T (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51: 5520–5525

  26. 26.

    Nagata Y, Abe M, Kobayashi M, Saiki S, Kotake T, Yoshikawa K, Ueda R, Nakayama E, Shiku H (1990) Point mutation of c-ras genes in human bladder and kidney cancer. Jpn J Cancer Res 81: 22–27

  27. 27.

    Nanus DM, Mentle IR, Motzer RJ, Bander NH, Albino AP (1990) Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol 143: 175–178

  28. 28.

    Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705–708

  29. 29.

    Ogawa O, Habuchi T, Kakehi Y, Koshiba M, Sugiyama T, Yoshida O (1992) Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res 52: 1881–1885

  30. 30.

    Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766–2770

  31. 31.

    Robson CJ, Churchill BM, Anderson W (1986) The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297–301

  32. 32.

    Rochlitz CF, Peter S, Willroth G, de Kant E, Lobeck H, Huhn D, Herrmann R (1992) Mutations in the ras protooncogenes are rare events in renal cell cancer. Eur J Cancer 28: 333–336

  33. 33.

    Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk N, Bos JL (1987) Mutational activation of the K-ras oncogene, possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 317: 929–935

  34. 34.

    Saiki RK, Gelfand DH, Stoffel S, Schalf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491

  35. 35.

    Sambrook J, Frisch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn, Cold Spring Harbor Laboratory, New York

  36. 36.

    Slamon DJ, deKernion JB, Verma IM, Cline MJ (1984) Expression of cellular oncogenes in human malignancies. Science 224: 256–262

  37. 37.

    Suzuki Y, Tamura G, Satodate R, Fujioka T (1992) Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn J Cancer Res 83: 233–235

  38. 38.

    Tamura G, Maesawa C, Suzuki Y, Ogasawara S, Terashima M, Saito K, Satodate R (1993) Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn J Cancer Res 84: 1015–1018

  39. 39.

    Uchida T, Wada C, Shitara T, Egawa S, Mashimo S, Koshiba K (1993) Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J Urol 150: 1298–1301

  40. 40.

    van den Berg E, van der Hout AH, Oosterhuis JW, Störkel S, Dijkhuizen T, Dam A, Zweers HMM, Mensink HJA, Buys CHCM, de Jong B (1993) Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histological classification. Int J Cancer 55: 223–227

  41. 41.

    Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525–532

  42. 42.

    Yamakawa K, Morita R, Takahashi E, Hori T, Ishikawa J, Nakamura Y (1991) A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res 51: 4704–4711

  43. 43.

    Zbar B, Brauch H, Talmadge C, Linehan M (1987) Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327: 721–724

Download references

Author information

Correspondence to Y. Suzuki.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Suzuki, Y., Tamura, G., Maesawa, C. et al. Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction. Vichows Archiv A Pathol Anat 424, 453–457 (1994).

Download citation

Key words

  • Tumour suppressor genes
  • ras oncogene Renal cell carcinoma
  • Polymerase chain reaction